International Edition
Latest News
Health

Wes Streeting Calls for ‘Cross-Party Consensus’ on Gender Identity Ahead of Puberty Blocker Trial | Gender

Streeting urges Badenoch to maintain cross-party consensus on gender identity services The health secretary, Wes Streeting, has called on the Conservatives to maintain the cross-party consensus on gender identity services built before the last election in a letter…

Wes Streeting Calls for ‘Cross-Party Consensus’ on Gender Identity Ahead of Puberty Blocker Trial | Gender

Streeting urges Badenoch to maintain cross-party consensus on gender identity services

The health secretary, Wes Streeting, has called on the Conservatives to maintain the cross-party consensus on gender identity services built before the last election in a letter to Kemi Badenoch.

Streeting wrote to the opposition leader on Friday urging her to “take the heat and the ideology” out of debate amid controversy over a puberty blocker trial for children.

Both parties committed to implementing the recommendations of a report by the leading paediatrician Hilary Cass focused on gender identity services for under 18s in England, published in April 2024 when the Conservatives were in government. Cass recommended a puberty blocker trial as part of a wider research program and supported a more “holistic” approach to care.

Badenoch and the shadow health secretary, Stuart Andrew, wrote to Streeting on 25 November, however, saying they were concerned NHS England was supporting a clinical trial involving drugs that halted natural puberty.

Related: Two UK clinical trials to assess impact of puberty blockers in young people

Cass found “remarkably weak” evidence the drugs were effective in treating gender-related distress, adding that ther was no good evidence on long-term outcomes.

She has said a trial is the only way forward in the attempt to understand if there are beneficial effects. The government has as banned the treatment for

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”